Celsus Therapeutics is a drug development company focusing on novel anti-inflammatory;first-in-class synthetic drugs.
Morria Biopharmaceuticals has raised €13M across 3 funding rounds, most recently a round in Oct 2013. Based in London, UK; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2013-10-01 | Other | €11M | — | View deal → |
| 2013-02-01 | Other | €838k | — | View deal → |
| 2012-12-01 | Other | €1.4M | — | View deal → |
